story of the week
Early Detection of Molecular Residual Disease and Risk Stratification in Stage I–III Colorectal Cancer via ctDNA Methylation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation
JAMA Oncol 2023 Apr 20;[EPub Ahead of Print], S Mo, L Ye, D Wang, L Han, S Zhou, H Wang, W Dai, Y Wang, W Luo, R Wang, Y Xu, S Cai, R Liu, Z Wang, G CaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.